Drawing for COMPASTEP

USPTO serial 79220999

COMPASTEP

Reviewed by CopyMark Law Group

Reg. 5598020Status 709
Filing date
Status date
Registration date
Nov 6, 2018
Examiner
HENRY, NAKIA D
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COMPASTEP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003CosmeticsSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of mobility disorders; nutritional supplements; plasters for medical purposes; wound dressingsSECTION 71 - CANCELLED—
010Medical apparatus and instruments for use in the therapy of pain and mobility diseases and disorders; inhalers for medical use; orthopedic and mobility aids, namely walking aids for medical useSECTION 71 - CANCELLED—
032Non-alcoholic beverages flavored with fruit; non-alcoholic carbonated beverages; non-alcoholic beverages flavored with tea; non-alcoholic beverages flavored with herbs; non-alcoholic malt beverages; non-alcoholic beverages flavored with coffee; preparations for making beverages, namely, instant powders, syrups, and concentrates to make fruit flavored drinksSECTION 71 - CANCELLED—
041Educational instruction, namely, seminars and workshops in the field of healthcare and wellbeing, as well as consultation in the healthcare field; providing online newsletters via e-mail concerning recent topics in the healthcare fieldSECTION 71 - CANCELLED—
044Providing medical information and consultation; providing medical information in the field of geriatrics; providing medical information regarding news and recent topics in the healthcare fieldSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 3, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 3, 2026INPCINVALIDATION PROCESSED—
May 14, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 23, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 23, 2025C71TCANCELLED SECTION 71—
Nov 6, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 3, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 31, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 31, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 2, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 1, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 12, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 12, 2019FIMPFINAL DISPOSITION PROCESSED—
Feb 6, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 6, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 21, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 21, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 17, 2018GPNXNOTIFICATION PROCESSED BY IB—
Aug 1, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 1, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 1, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2018CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 13, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 2, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 2, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 28, 2018ALIEASSIGNED TO LIE—
Jun 14, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 14, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 14, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 14, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 14, 2017RFRRREFUSAL PROCESSED BY MPU—
Dec 1, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 22, 2017DOCKASSIGNED TO EXAMINER—
Nov 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance